Enliven Therapeutics Inc. (Nasdaq: ELVN) reported this week that as of the end of 2025, the clinical-stage precision oncology company has $462.6 million in cash and equivalents, enough runway to fund ...
Abstract: Motivated by the critical challenges posed by modern wireless data trends and RFIC layouts, an aperiodic phased array topology which remains scalable to an arbitrary number of elements is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results